← brief for 2026-10-22 · Slowing decline

Cystatin C, Neutrophil Gelatinase-associated Lipocalin, and Pro-atrial Natriuretic Peptide as Biomarkers in the Assessment of Diabetic Nephropathy Patients.

Article C Peer reviewed Observational

Key takeaways

This study tested if certain blood markers can track the severity of diabetic kidney disease. It followed 52 patients with the condition and 52 healthy controls. The results show a link between these markers and disease severity. This is an observational study, so it does not prove cause and effect.

Who did this work

Acharya NN · Biswas K · Sahasarajitha SS · Kumar D · Shekhanawar MS · Nimbal NV

Source

Article · PubMed, CKD severity and reversal · 2026 Oct 20
https://pubmed.ncbi.nlm.nih.gov/42904356/